A Parkinson s Disease and related disorders
|
|
- Dina Walters
- 6 years ago
- Views:
Transcription
1 A Parkinson s Disease and related disorders 10 November 2016 Marinela Vavla marinela.vavla@kcl.ac.uk
2 Learning objectives Basal ganglia: components and localization (inter)connections and functions Parkinson s Disease (and related motor disorders) Clinical presentation of PD Risk factors Molecular basis of PD Neuropathology/neurodegeneration (pathways) Treatment
3 Anatomy of the Basal Ganglia Basal Ganglia: CAUDATE STRIATUM PUTAMEN NUCLEUS ACCUMBENS GLOBUS PALLIDUS (GPe and GPi) SUBTHALAMIC NUCLEUS (STN) SUBSTANTIA NIGRA (SNpc and SNpr)
4 Nucleus Accumbens See n. 17. Tamraz and Comair, Atlas of regional anatomy of the Brain using MRI functions
5 Anatomy of the Basal Ganglia
6 More Basal Ganglia
7 Basal Ganglia Circuitry INPUTS Cortex (Glu) Intralaminal nuclei of thalamus SN in the midbrain (DA) Raphe nuclei (Serotonine) INTERCONNECTIONS Striatum Striato Nigral Nigro Striatal GP Pallido Subthalamic Subthalamic Pallidal Striato Pallidal OUTPUTS (From Gpi and SNpr) STN Ventral Anterior Nucleus
8 A Corticostriatal Thalamocortical Motor Circuit D 2 D 1 SNc
9 Direct pathway Putamen GPi, SNr Reduce output from GPi (GABA) Thalamus disinhibited Allows movement (cortex) Malfunction PD Bradykinesia Indirect pathway Putamen ( ) GPe ( ) STN (+) GPi Net output from GPi GABA Inhibits thalamus Inhibits movement (cortex) Malfunction HD/Chorea Basal Ganglia Circuitry
10 Relationship between the centre surround organization of the Gpi to inputs from the Striatum and STN.
11 What do the Basal Ganglia do? Motor preparation Action selection Reward based learning Exploratory behaviour Goal oriented behaviour Timing Action gating
12 Motor Disorders Hypokinetic disorders (PD) Akinesis Bradykinesis Hyperkinetic disorders (HD, HEMIBALLISMUS) Dyskinesis Athetosis, Ballism, Chorea, Dystonia
13 SNpc: PD Putamen: Dystonia Striatum (caudate and putamen): HD/Chorea STN, GPi: Hemiballism SNpr: Saccades/Involuntary eye movements Cortico striatal pallidalthalamic: Tourette, OCD. Damage to the BG
14 Parkinson s Disease
15 Dr James Parkinson ( )
16 Definition of PD Involuntary tremulous motion with lessened muscular power, in parts not in action and even when supported with a propensity to bend the trunk forwards and to pass from walking to a running pace. Termed Parkinson s Disease by Charcot
17 Presentation of PD: cardinal symptoms Tremor Bradykinesia Rigidity & Postural Instability
18 Constant Levels of Dopamine are Vital for Normal Movement Striatum Excitatory cortical input Dopaminergic regulatory input Substantia nigra Basal ganglia In the brain, constant levels of dopamine are required to Regulate cortical excitation of striatal neurons Stabilize the firing rate and excitability of striatal neurons Modulate plasticity of striatal neurons (long term potentiation) Normal motor function Olanow et al, 2006
19 Parkinson s Disease PD is characterized of loss of dopaminergic neurons in the SNpc.
20 Why/How does all this happen? Structure Function Pathology
21 Many Years Ago... PD was the first example of brain disorder resulting from a deficiency of a neurotransmitter Mid 1950s A. Carlson showed that 80% of the brain s DA is in the basal ganglia. O. Horynekiewict found that the brain of patients with PD are deficient in DA in the striatum and most severely in the putamen. Early 1960s PD was shown to result largely from the degeneration of the DAergic neurons in the SNpc. W. Brikmayer and O. Horynekiewict found that i.v L DOPA could provide a dramatic (but brief!) reversal of symptoms G. Cotzias demonstrated that gradual increase in p.o. L DOPA could provide significant and continuous benefit to the PD symptoms.
22 Neuropathology Death of SNpc dopaminergic neurons Presence of Lewy body and Lewy neurites intracytoplasmatic inclusions Immunostaining with an antibody against synuclein reveals a Lewy body (black arrow) with an intensely immunoreactive central zone surrounded by a faintly immunoreactive peripheral zone (left).
23 Risk Factors Genetic factors Environmental toxins Agricultural toxins (Paraquat, Rotenone) Drugs of abuse (Amphetamine, Cocaine) MPTP(1 methyl 4 phenyl 1,2,3,6 tetrahydropyridine) Protein aggregation Oxidative stress Metals (Fe, Al, Mn, Cu) Age Gender Premotor features (olfactory dysfunction, constipation, depression/anxiety and REM sleep disorders)
24 Lill, 2016
25 Genetic factors Lubbe and Morris, 2014
26 Molecular Basis of Autosomal Dominant PD A synuclein SNCA: Regulates the neurotransmitter vesicle function at the presynaptic membrane due to its ability to bind and stabilize lipid bilayers and its enrichment in presynaptic terminals Mutations + gene dosage effect lead to α syn protofibril formation which aggregates in Lewy bodies and Lewy neurites Α syn toxicity may involve the leakage of DA from synaptic vesicles because of perforation of the vesicular membranes Might be implicated in impaired cellular autophagy LRRK2/Dardarin PARK8: Cytoplasmic protein which might be associated to intracell. membranes as outer mitochondria, ER and Golgi apparatus. Mutations identified in α syn+ LB pathology or tau+ neurofibrillary tangle pathology suggesting a possible common role in the phosphorylation/processing of these two proteins
27 Molecular Basis of Autosomal Recessive PD Parkin: Ubiquitinates proteins targeting them for proteosomal degradation, and also implicated in cellular autophagy Mutations lead to impairment in binding the putative substrates and/or loss of function Studies of Parkin k.o. mice suggest that Parkin loss of function may lead to mitochondrial dysfunction and oxidative stress PINK1 (PTEN induced kinase 1) Phosphorylates ser/thre residues on basic substrates Mutations lead to disruption of kinase activity affecting the mitochondrial function and incresing cellular susceptibility to stress (TRAP1, Omi/HtrA2) DJ 1 Present in the brain and pheripheral tissues. Present in the cytoplasm with a small pool associated with mitochondria. It is involved in the oxidative stress response by acting as a redox dependent chaperone ATP13A2 Encodes for a P type ATPase which maintains the ion gradient across the cell membrane Although it is still unclear, in vitro models have shown that wt ATP13A2 is localized in lysosomes. The mutated proteins were retained in the ER and degraded by the proteasome Mutations cause an early onset parkinsonism with pyramidal degeneration and dementia. It is suspected to be caused by proteasomal degeneration due to an overload of retained protein
28 Pathways to PD Potential pathogenic mechanisms in PD: Ubiquitin proteasomal dysfunction Mitochondrial dysfunction & Oxidative stress Autophagy impairment
29 Pathways to PD
30 Animal Models in PD Ideal or suitable animal model of PD Characterized by progressive and significant loss of DA neurons and the loss of some non DA neurons, with onset during adulthood. Mimicking the clinical manifestation of the human disease, including the motor phenotype that includes bradykinesia, rigidity, postural instability and resting tremor, with motor features being responsive to L DOPA therapy. Rodent and Primate models: have been useful to Dissect the disease mechanism Improve therapeutic outcomes Toxin based models 6 OHDA Rotenone Paraquat MPTP Genetic based models More attractive alternatives: Zebrafish (Danio rerio) Fruit fly (Drosophila melanogaster) Auran (Xenopus laevis) Nematode (Caenorhabditis elegans) Yeast (Saccharomyces cerevisiae) Pienaar et al., 2012, Le et al., 2014
31 DaTSCAN (FP CIT SPECT) SPECT imaging of membrane dopamine transporters. Detects degeneration of dopaminergic nigrostriatal pathway eg presynaptic Parkinsonian syndromes Normal commas Abnormal retreating commas and full stops Note the asymmetry of uptake characteristic of PD but cannot distinguish PD from other forms of presynaptic parkinsonism eg MSA PSP Caudate Putamen
32 Differential Diagnosis PARKINSONISM Tremor Tremor Rigidity Resting or Bradykinesia Postural Postural instability /gait difficulty TREMOR DISORDERS Essential tremor Dystonic tremor Parkinson s disease Multiple System Atrophy Progressive Supranuclear Palsy Drug induced Vascular Structural Toxins Infections Metabolic Degenerative Non degenerative
33
34 Not all PD Symptoms are due to Dopamine Degeneration GABA GLU Ach STN:subthalamic nucleus; GPi:globus pallidus interna; GPe:external segment; SNc:substantia nigra pars compacta; VTA:ventral tegamental area Lang & Obeso, 2004
35 Braak Staging of Lewy Bodies Braak H, et al. J Neurology. 2002;249(suppl 3):
36 Symtoms of Parkinson s disease PD AUTONOMIC Motor syndrome (MS) Untreated Bradykinesia Rigidity Tremor Micrographia Gait problems Treated Dyskinesias Fluctuations AUTONOMIC NON MOTOR SYMPTOMS COMPLEX Gastrointesinal Genitourinary Sleep Pain Sexual Function Cognition Apathy Fatigue Misclleaneous: Olfactory Diplopia Hyperhidrosis Weight Change Chaudhuri et al,lancet Neurology 2006
37 Dementia in PD Pathological findings in a PDD case (a) Amyloid β (A4) senile plaques and (b) tau positive neurofibrillary tangles in hippocampus (original magnification, x200) (c) α Synuclein stained neocortical Lewy bodies (d) hippocampal Lewy neurites
38 Downregulation of Synthesis and Release of Dopamine
39 Symptomatic Principles of therapy I Replacement of the missing neurotransmitter DA agonists, Symptomatic and Neuroprotective MAO B inhibitors Neurosurgical therapies Surgical ablation therapy (Pallidotomy, Thalamotomy) Deep Brain Stimulation Anti Oxidant therapy: neuroprotection in order to slow the progression
40 Principles of Therapy II Gene therapy: aims to protect and repair neuronal damage Gene targets include α syn and Parkin Locations SNpc and STN Cell based therapies Transplant of foetal ventral mesencephalic tissue BUT Ethical Issues (two human trials showed negative results, and thereby compromising (?) the entire concept of cell replacement approach. Alternative: use of embryonic stem cells or committed neural precursors
41 Summary BG consists of Striatum, GP, STN and SN BG is importantly connected to other brain regions via afferent and efferent projections, and also interconnections between individual BG nuclei Motor control is mediated via the direct and indirect pathways in the BG circuitry BG is implicated in motor and non motor functions Damage in different nuclei of the BG may cause different types of motor disorders: hypo /hyperkinetic disorders PD is presented with tremor, bradykinesias and rigidity. Other motor and non motor symptoms might be present PD is caused by formation of LBs and LNs in the SNpc DAergic neurons leading to neuronal death Genetic studies have contributed to a better understanding of molecular pathways leading to neurodegeneration Different animal models have been used to study PD enlightening the current knowledge on pathogenic mechanisms Treatments have a propensity to control symptoms, although none (?) can halt the PD progression
Neurodegenerative Disease. April 12, Cunningham. Department of Neurosciences
Neurodegenerative Disease April 12, 2017 Cunningham Department of Neurosciences NEURODEGENERATIVE DISEASE Any of a group of hereditary and sporadic conditions characterized by progressive dysfunction,
More informationBasal ganglia Sujata Sofat, class of 2009
Basal ganglia Sujata Sofat, class of 2009 Basal ganglia Objectives Describe the function of the Basal Ganglia in movement Define the BG components and their locations Describe the motor loop of the BG
More informationThe motor regulator. 1) Basal ganglia/nucleus
The motor regulator 1) Basal ganglia/nucleus Neural structures involved in the control of movement Basal Ganglia - Components of the basal ganglia - Function of the basal ganglia - Connection and circuits
More informationAnatomy of the basal ganglia. Dana Cohen Gonda Brain Research Center, room 410
Anatomy of the basal ganglia Dana Cohen Gonda Brain Research Center, room 410 danacoh@gmail.com The basal ganglia The nuclei form a small minority of the brain s neuronal population. Little is known about
More informationBasal Ganglia. Steven McLoon Department of Neuroscience University of Minnesota
Basal Ganglia Steven McLoon Department of Neuroscience University of Minnesota 1 Course News Graduate School Discussion Wednesday, Nov 1, 11:00am MoosT 2-690 with Paul Mermelstein (invite your friends)
More informationCOGNITIVE SCIENCE 107A. Motor Systems: Basal Ganglia. Jaime A. Pineda, Ph.D.
COGNITIVE SCIENCE 107A Motor Systems: Basal Ganglia Jaime A. Pineda, Ph.D. Two major descending s Pyramidal vs. extrapyramidal Motor cortex Pyramidal system Pathway for voluntary movement Most fibers originate
More informationDamage on one side.. (Notes) Just remember: Unilateral damage to basal ganglia causes contralateral symptoms.
Lecture 20 - Basal Ganglia Basal Ganglia (Nolte 5 th Ed pp 464) Damage to the basal ganglia produces involuntary movements. Although the basal ganglia do not influence LMN directly (to cause this involuntary
More informationA. General features of the basal ganglia, one of our 3 major motor control centers:
Reading: Waxman pp. 141-146 are not very helpful! Computer Resources: HyperBrain, Chapter 12 Dental Neuroanatomy Suzanne S. Stensaas, Ph.D. March 1, 2012 THE BASAL GANGLIA Objectives: 1. What are the main
More informationA. General features of the basal ganglia, one of our 3 major motor control centers:
Reading: Waxman pp. 141-146 are not very helpful! Computer Resources: HyperBrain, Chapter 12 Dental Neuroanatomy Suzanne S. Stensaas, Ph.D. April 22, 2010 THE BASAL GANGLIA Objectives: 1. What are the
More informationParkinsonism or Parkinson s Disease I. Symptoms: Main disorder of movement. Named after, an English physician who described the then known, in 1817.
Parkinsonism or Parkinson s Disease I. Symptoms: Main disorder of movement. Named after, an English physician who described the then known, in 1817. Four (4) hallmark clinical signs: 1) Tremor: (Note -
More informationPathogenesis of Degenerative Diseases and Dementias. D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria)
Pathogenesis of Degenerative Diseases and Dementias D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria) Dementias Defined: as the development of memory impairment and other cognitive deficits
More informationMaking Things Happen 2: Motor Disorders
Making Things Happen 2: Motor Disorders How Your Brain Works Prof. Jan Schnupp wschnupp@cityu.edu.hk HowYourBrainWorks.net On the Menu in This Lecture In the previous lecture we saw how motor cortex and
More informationCheyenne 11/28 Neurological Disorders II. Transmissible Spongiform Encephalopathy
Cheyenne 11/28 Neurological Disorders II Transmissible Spongiform Encephalopathy -E.g Bovine4 Spongiform Encephalopathy (BSE= mad cow disease), Creutzfeldt-Jakob disease, scrapie (animal only) -Sporadic:
More informationTeach-SHEET Basal Ganglia
Teach-SHEET Basal Ganglia Purves D, et al. Neuroscience, 5 th Ed., Sinauer Associates, 2012 Common organizational principles Basic Circuits or Loops: Motor loop concerned with learned movements (scaling
More informationBasal Ganglia George R. Leichnetz, Ph.D.
Basal Ganglia George R. Leichnetz, Ph.D. OBJECTIVES 1. To understand the brain structures which constitute the basal ganglia, and their interconnections 2. To understand the consequences (clinical manifestations)
More informationGBME graduate course. Chapter 43. The Basal Ganglia
GBME graduate course Chapter 43. The Basal Ganglia Basal ganglia in history Parkinson s disease Huntington s disease Parkinson s disease 1817 Parkinson's disease (PD) is a degenerative disorder of the
More informationThis is a free sample of content from Parkinson's Disease. Click here for more information or to buy the book.
A AADC. See Aromatic amino acid decarboxylase AAV. See Adeno-associated virus Acetylcholine (ACh), functional imaging, 174 175 ACh. See Acetylcholine Adaptive immune system central nervous system, 381
More informationVL VA BASAL GANGLIA. FUNCTIONAl COMPONENTS. Function Component Deficits Start/initiation Basal Ganglia Spontan movements
BASAL GANGLIA Chris Cohan, Ph.D. Dept. of Pathology/Anat Sci University at Buffalo I) Overview How do Basal Ganglia affect movement Basal ganglia enhance cortical motor activity and facilitate movement.
More informationBasal Ganglia. Today s lecture is about Basal Ganglia and it covers:
Basal Ganglia Motor system is complex interaction between Lower motor neurons (spinal cord and brainstem circuits) and Upper motor neurons (pyramidal and extrapyramidal tracts) plus two main regulators
More informationMovement Disorders: A Brief Overview
Movement Disorders: A Brief Overview Albert Hung, MD, PhD Massachusetts General Hospital Harvard Medical School August 17, 2006 Cardinal Features of Parkinsonism Tremor Rigidity Bradykinesia Postural imbalance
More informationFirst described by James Parkinson in his classic 1817 monograph, "An Essay on the Shaking Palsy"
Parkinson's Disease First described by James Parkinson in his classic 1817 monograph, "An Essay on the Shaking Palsy" Parkinson s disease (PD) is a neurological disorder characterized by a progressive
More informationStrick Lecture 4 March 29, 2006 Page 1
Strick Lecture 4 March 29, 2006 Page 1 Basal Ganglia OUTLINE- I. Structures included in the basal ganglia II. III. IV. Skeleton diagram of Basal Ganglia Loops with cortex Similarity with Cerebellar Loops
More informationOverview. Overview. Parkinson s disease. Secondary Parkinsonism. Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits
Overview Overview Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits The differential diagnosis of Parkinson s disease Primary vs. Secondary Parkinsonism Proteinopathies:
More informationConnections of basal ganglia
Connections of basal ganglia Introduction The basal ganglia, or basal nuclei, are areas of subcortical grey matter that play a prominent role in modulating movement, as well as cognitive and emotional
More informationMaking Every Little Bit Count: Parkinson s Disease. SHP Neurobiology of Development and Disease
Making Every Little Bit Count: Parkinson s Disease SHP Neurobiology of Development and Disease Parkinson s Disease Initially described symptomatically by Dr. James Parkinson in 1817 in An Essay on the
More informationVisualization and simulated animations of pathology and symptoms of Parkinson s disease
Visualization and simulated animations of pathology and symptoms of Parkinson s disease Prof. Yifan HAN Email: bctycan@ust.hk 1. Introduction 2. Biochemistry of Parkinson s disease 3. Course Design 4.
More informationParkinson s Disease in the Elderly A Physicians perspective. Dr John Coyle
Parkinson s Disease in the Elderly A Physicians perspective Dr John Coyle Overview Introduction Epidemiology and aetiology Pathogenesis Diagnosis and clinical features Treatment Psychological issues/ non
More informationParts of the motor circuits
MOVEMENT DISORDERS Parts of the motor circuits cortical centers: there are centers in all the cortical lobes subcortical centers: caudate nucleus putamen pallidum subthalamical nucleus (Luys) nucleus ruber
More informationBasal Ganglia General Info
Basal Ganglia General Info Neural clusters in peripheral nervous system are ganglia. In the central nervous system, they are called nuclei. Should be called Basal Nuclei but usually called Basal Ganglia.
More informationThe Wonders of the Basal Ganglia
Basal Ganglia The Wonders of the Basal Ganglia by Mackenzie Breton and Laura Strong /// https://kin450- neurophysiology.wikispaces.com/basal+ganglia Introduction The basal ganglia are a group of nuclei
More informationExtrapyramidal Motor System. Basal Ganglia or Striatum. Basal Ganglia or Striatum 3/3/2010
Extrapyramidal Motor System Basal Ganglia or Striatum Descending extrapyramidal paths receive input from other parts of motor system: From the cerebellum From the basal ganglia or corpus striatum Caudate
More informationUNIVERSITY OF JORDAN FACULTY OF MEDICINE DEPARTMENT OF PHYSIOLOGY & BIOCHEMISTRY NEUROPHYSIOLOGY (MEDICAL) Spring, 2014
UNIVERSITY OF JORDAN FACULTY OF MEDICINE DEPARTMENT OF PHYSIOLOGY & BIOCHEMISTRY NEUROPHYSIOLOGY (MEDICAL) Spring, 2014 Textbook of Medical Physiology by: Guyton & Hall, 11 th edition 2006 Eman Al-Khateeb,
More informationNS219: Basal Ganglia Anatomy
NS219: Basal Ganglia Anatomy Human basal ganglia anatomy Analagous rodent basal ganglia nuclei Basal ganglia circuits: the classical model of direct and indirect pathways + Glutamate + - GABA - Gross anatomy
More informationChapter 8. Parkinsonism. M.G.Rajanandh, Dept. of Pharmacy Practice, SRM College of Pharmacy, SRM University.
Chapter 8 Parkinsonism M.G.Rajanandh, Dept. of Pharmacy Practice, SRM College of Pharmacy, SRM University. Definition of Parkinson s Disease Parkinson's disease is a progressive, neurodegenerative disease
More informationClinical Features and Treatment of Parkinson s Disease
Clinical Features and Treatment of Parkinson s Disease Richard Camicioli, MD, FRCPC Cognitive and Movement Disorders Department of Medicine University of Alberta 1 Objectives To review the diagnosis and
More informationLecture XIII. Brain Diseases I - Parkinsonism! Brain Diseases I!
Lecture XIII. Brain Diseases I - Parkinsonism! Bio 3411! Wednesday!! Lecture XIII. Brain Diseases - I.! 1! Brain Diseases I! NEUROSCIENCE 5 th ed! Page!!Figure!!Feature! 408 18.9 A!!Substantia Nigra in
More informationIII./3.1. Movement disorders with akinetic rigid symptoms
III./3.1. Movement disorders with akinetic rigid symptoms III./3.1.1. Parkinson s disease Parkinson s disease (PD) is the second most common neurodegenerative disorder worldwide after Alzheimer s disease.
More informationMalattia di Parkinson: patogenesi molecolare e nuove strategie terapeutiche
LA NEUROSONOLOGIA NELLE PATOLOGIE DEGENERATIVE E VASCOLARI CEREBRALI San Benedetto del Tronto 6-8 novembre 2017 Malattia di Parkinson: patogenesi molecolare e nuove strategie terapeutiche Giuseppe De Michele
More informationSTRUCTURE AND CIRCUITS OF THE BASAL GANGLIA
STRUCTURE AND CIRCUITS OF THE BASAL GANGLIA Rastislav Druga Department of Anatomy, Second Faculty of Medicine 2017 Basal ganglia Nucleus caudatus, putamen, globus pallidus (medialis et lateralis), ncl.
More informationThe Biology of Parkinson s Disease and its treatments
The Biology of Parkinson s Disease and its treatments Paola Sacchetti, Ph.D. Assistant Professor Director MS Neuroscience Department of Biology University of Hartford, CT psacchett@hartford.edu (860)768-5926
More informationParkinson s Disease. Prevalence. Mark S. Baron, M.D. Cardinal Features. Clinical Characteristics. Not Just a Movement Disorder
Prevalence Parkinson s Disease Mark S. Baron, M.D. Associate Professor of Neurology Movement Disorders Section VCU School of Medicine Common disorder Approaching 1% by 65 yrs of age, 2% by 80 yrs of age
More information2/14/2013. The Pathogenesis of Parkinson s Disease. February, inherited forms of PD. Autosomal Recessive Parkinson s Disease
inherited forms of PD The Pathogenesis of Parkinson s Disease February, 2013 PARK1 dominant α-synuclein presynaptic protein PARK2 recessive parkin E3 ubiquitin ligase PARK3 dominant 2p13? PARK4 dominant
More informationDeep Brain Stimulation Surgery for Parkinson s Disease
Deep Brain Stimulation Surgery for Parkinson s Disease Demystifying Medicine 24 January 2012 Kareem A. Zaghloul, MD, PhD Staff Physician, Surgical Neurology Branch NINDS Surgery for Parkinson s Disease
More informationParkinson's Disease KP Update
Parkinson's Disease KP Update Andrew Imbus, PA-C Neurology, Movement Disorders Kaiser Permanente, Los Angeles Medical Center No disclosures "I often say now I don't have any choice whether or not I have
More informationImaging biomarkers for Parkinson s disease
3 rd Congress of the European Academy of Neurology Amsterdam, The Netherlands, June 24 27, 2017 Teaching Course 6 MDS-ES/EAN: Neuroimaging in movement disorders - Level 2 Imaging biomarkers for Parkinson
More informationFor more information about how to cite these materials visit
Author(s): Peter Hitchcock, PH.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Non-commercial Share Alike 3.0 License: http://creativecommons.org/licenses/by-nc-sa/3.0/
More informationBasal Ganglia. Introduction. Basal Ganglia at a Glance. Role of the BG
Basal Ganglia Shepherd (2004) Chapter 9 Charles J. Wilson Instructor: Yoonsuck Choe; CPSC 644 Cortical Networks Introduction A set of nuclei in the forebrain and midbrain area in mammals, birds, and reptiles.
More informationASHI691: Why We Fall Apart: The Neuroscience and Neurophysiology of Aging. Dr. Olav E. Krigolson Lecture 5: PARKINSONS DISEASE
ASHI691: Why We Fall Apart: The Neuroscience and Neurophysiology of Aging Dr. Olav E. Krigolson krigolson@uvic.ca Lecture 5: PARKINSONS DISEASE The Basal Ganglia Primary motor cortex Execution of movement
More informationParkinson Disease. Lorraine Kalia, MD, PhD, FRCPC. Presented by: Ontario s Geriatric Steering Committee
Parkinson Disease Lorraine Kalia, MD, PhD, FRCPC Key Learnings Parkinson Disease (L. Kalia) Key Learnings Parkinson disease is the most common but not the only cause of parkinsonism Parkinson disease is
More informationFDG-PET e parkinsonismi
Parkinsonismi FDG-PET e parkinsonismi Valentina Berti Dipartimento di Scienze Biomediche, Sperimentali e Cliniche Sez. Medicina Nucleare Università degli Studi di Firenze History 140 PubMed: FDG AND parkinsonism
More informationDISORDERS OF THE MOTOR SYSTEM. Jeanette J. Norden, Ph.D. Professor Emerita Vanderbilt University School of Medicine
DISORDERS OF THE MOTOR SYSTEM Jeanette J. Norden, Ph.D. Professor Emerita Vanderbilt University School of Medicine THE MOTOR SYSTEM To understand disorders of the motor system, we need to review how a
More informationComputational cognitive neuroscience: 8. Motor Control and Reinforcement Learning
1 Computational cognitive neuroscience: 8. Motor Control and Reinforcement Learning Lubica Beňušková Centre for Cognitive Science, FMFI Comenius University in Bratislava 2 Sensory-motor loop The essence
More informationChapter 8. Control of movement
Chapter 8 Control of movement 1st Type: Skeletal Muscle Skeletal Muscle: Ones that moves us Muscles contract, limb flex Flexion: a movement of a limb that tends to bend its joints, contraction of a flexor
More informationMovement Disorders. Psychology 372 Physiological Psychology. Background. Myasthenia Gravis. Many Types
Background Movement Disorders Psychology 372 Physiological Psychology Steven E. Meier, Ph.D. Listen to the audio lecture while viewing these slides Early Studies Found some patients with progressive weakness
More informationImpact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson s Disease
Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson s Disease FABIO G. TEIXEIRA,MIGUEL M.CARVALHO KRISHNA M. PANCHALINGAM ANA J.RODRIGUES
More information神經解剖學 NEUROANATOMY BASAL NUCLEI 盧家鋒助理教授臺北醫學大學醫學系解剖學暨細胞生物學科臺北醫學大學醫學院轉譯影像研究中心.
神經解剖學 NEUROANATOMY BASAL NUCLEI 盧家鋒助理教授臺北醫學大學醫學系解剖學暨細胞生物學科臺北醫學大學醫學院轉譯影像研究中心 http://www.ym.edu.tw/~cflu OUTLINE Components and Pathways of the Basal Nuclei Functions and Related Disorders of the Basal Nuclei
More informationDIFFERENTIAL DIAGNOSIS SARAH MARRINAN
Parkinson s Academy Registrar Masterclass Sheffield DIFFERENTIAL DIAGNOSIS SARAH MARRINAN 17 th September 2014 Objectives Importance of age in diagnosis Diagnostic challenges Brain Bank criteria Differential
More informationBasal ganglia motor circuit
Parkinson s Disease Basal ganglia motor circuit 1 Direct pathway (gas pedal) 2 Indirect pathway (brake) To release or augment the tonic inhibition of GPi on thalamus Direct pathway There is a tonic inhibition
More informationDeep Brain Stimulation: Surgical Process
Deep Brain Stimulation: Surgical Process Kia Shahlaie, MD, PhD Assistant Professor Bronte Endowed Chair in Epilepsy Research Director of Functional Neurosurgery Minimally Invasive Neurosurgery Department
More informationDr Barry Snow. Neurologist Auckland District Health Board
Dr Barry Snow Neurologist Auckland District Health Board Dystonia and Parkinson s disease Barry Snow Gowers 1888: Tetanoid chorea Dystonia a movement disorder characterized by sustained or intermittent
More informationDifferential Diagnosis of Hypokinetic Movement Disorders
Differential Diagnosis of Hypokinetic Movement Disorders Dr Donald Grosset Consultant Neurologist - Honorary Professor Institute of Neurological Sciences - Glasgow University Hypokinetic Parkinson's Disease
More informationParkinson s disease Therapeutic strategies. Surat Tanprawate, MD Division of Neurology University of Chiang Mai
Parkinson s disease Therapeutic strategies Surat Tanprawate, MD Division of Neurology University of Chiang Mai 1 Scope Modality of treatment Pathophysiology of PD and dopamine metabolism Drugs Are there
More informationMOVEMENT OUTLINE. The Control of Movement: Muscles! Motor Reflexes Brain Mechanisms of Movement Mirror Neurons Disorders of Movement
MOVEMENT 2 Dr. Steinmetz 3 OUTLINE The Control of Movement: Muscles! Motor Reflexes Brain Mechanisms of Movement Mirror Neurons Disorders of Movement Parkinson s Disease Huntington s Disease 1 4 TYPES
More informationMODULE 6: CEREBELLUM AND BASAL GANGLIA
MODULE 6: CEREBELLUM AND BASAL GANGLIA This module will summarize the important neuroanatomical and key clinical concepts from Chapters 15 and 16 of the textbook for the course. The first part of this
More informationExam 2 PSYC Fall (2 points) Match a brain structure that is located closest to the following portions of the ventricular system
Exam 2 PSYC 2022 Fall 1998 (2 points) What 2 nuclei are collectively called the striatum? (2 points) Match a brain structure that is located closest to the following portions of the ventricular system
More informationBiological Bases of Behavior. 8: Control of Movement
Biological Bases of Behavior 8: Control of Movement m d Skeletal Muscle Movements of our body are accomplished by contraction of the skeletal muscles Flexion: contraction of a flexor muscle draws in a
More informationGangli della Base: un network multifunzionale
Gangli della Base: un network multifunzionale Prof. Giovanni Abbruzzese Centro per la Malattia di Parkinson e i Disordini del Movimento DiNOGMI, Università di Genova IRCCS AOU San Martino IST Basal Ganglia
More informationDr. Farah Nabil Abbas. MBChB, MSc, PhD
Dr. Farah Nabil Abbas MBChB, MSc, PhD The Basal Ganglia *Functions in association with motor cortex and corticospinal pathways. *Regarded as accessory motor system besides cerebellum. *Receive most of
More informationLevodopa vs. deep brain stimulation: computational models of treatments for Parkinson's disease
Levodopa vs. deep brain stimulation: computational models of treatments for Parkinson's disease Abstract Parkinson's disease (PD) is a neurodegenerative disease affecting the dopaminergic neurons of the
More informationScott J Sherman MD, PhD The University of Arizona PARKINSON DISEASE
Scott J Sherman MD, PhD The University of Arizona PARKINSON DISEASE LEARNING OBJECTIVES The Course Participant will: 1. Be familiar with the pathogenesis of Parkinson s Disease (PD) 2. Understand clinical
More informationUpdate on functional brain imaging in Movement Disorders
Update on functional brain imaging in Movement Disorders Mario Masellis, MSc, MD, FRCPC, PhD Assistant Professor & Clinician-Scientist Sunnybrook Health Sciences Centre University of Toronto 53 rd CNSF
More informationEvaluation of Parkinson s Patients and Primary Care Providers
Evaluation of Parkinson s Patients and Primary Care Providers 2018 Movement Disorders Half Day Symposium Elise Anderson MD Medical Co-Director, PBSI Movement Disorders 6/28/2018 1 Disclosures GE Speaker,
More informationModeling Parkinson s disease: systems to test gene-environment interactions
Modeling Parkinson s disease: systems to test gene-environment interactions Jason Cannon, Ph.D. Pittsburgh Institute of Neurodegenerative Diseases University of Pittsburgh Outline Parkinson s disease (PD)
More informationUNDERSTANDING PARKINSON S DISEASE
UNDERSTANDING PARKINSON S DISEASE WHAT IS PARKINSON S DISEASE? A progressive disease of the nervous system marked by tremor, muscular rigidity, and slow, imprecise movement, chiefly affecting middleaged
More informationEMERGING TREATMENTS FOR PARKINSON S DISEASE
EMERGING TREATMENTS FOR PARKINSON S DISEASE Katerina Markopoulou, MD, PhD Director Neurodegenerative Diseases Program Department of Neurology NorthShore University HealthSystem Clinical Assistant Professor
More informationTranscranial sonography in movement disorders
Transcranial sonography in movement disorders Uwe Walter 1st Residential Training of the European Society of Neurosonology and Cerebral Hemodynamics September 7-12, 2008 Bertinoro, Italy Department of
More informationEvaluation and Management of Parkinson s Disease in the Older Patient
Evaluation and Management of Parkinson s Disease in the Older Patient David A. Hinkle, MD, PhD Comprehensive Movement Disorders Clinic Pittsburgh Institute for Neurodegenerative Diseases University of
More informationLearnings from Parkinson s disease: Critical role of Biomarkers in successful drug development
Learnings from Parkinson s disease: Critical role of Biomarkers in successful drug development Ken Marek Coalition Against Major Diseases and FDA 2014 Annual Scientific Workshop Oct 2014 Disclosure Co-founder
More informationnucleus accumbens septi hier-259 Nucleus+Accumbens birnlex_727
Nucleus accumbens From Wikipedia, the free encyclopedia Brain: Nucleus accumbens Nucleus accumbens visible in red. Latin NeuroNames MeSH NeuroLex ID nucleus accumbens septi hier-259 Nucleus+Accumbens birnlex_727
More informationCN V! touch! pain! Touch! P/T!
CN V! touch! pain! Touch! P/T! Visual Pathways! L! R! B! A! C! D! LT! E! F! RT! G! hypothalamospinal! and! ALS! Vestibular Pathways! 1. Posture/Balance!!falling! 2. Head Position! 3. Eye-Head Movements
More information1/2/2019. Basal Ganglia & Cerebellum a quick overview. Outcomes you want to accomplish. MHD-Neuroanatomy Neuroscience Block. Basal ganglia review
This power point is made available as an educational resource or study aid for your use only. This presentation may not be duplicated for others and should not be redistributed or posted anywhere on the
More informationParkinson s Disease Initial Clinical and Diagnostic Evaluation. J. Timothy Greenamyre, MD, PhD
Parkinson s Disease Initial Clinical and Diagnostic Evaluation J. Timothy Greenamyre, MD, PhD Involuntary tremulous motion, with lessened muscular power, in parts not in action and even when supported
More informationMovement Disorders Will Garrett, M.D Assistant Professor of Neurology
Movement Disorders Will Garrett, M.D Assistant Professor of Neurology I. The Basal Ganglia The basal ganglia are composed of several structures including the caudate and putamen (collectively called the
More informationLa neurosonologia. Ecografia cerebrale e nuove applicazioni nelle malattie neurodegenerative. Nelle patologie degenerative e vascolari cerebrali
La neurosonologia Nelle patologie degenerative e vascolari cerebrali Andrea Pilotto Ecografia cerebrale e nuove applicazioni nelle malattie neurodegenerative Prof. Daniela Berg Department of Neurodegeneration
More informationMotor System Hierarchy
Motor Pathways Lectures Objectives Define the terms upper and lower motor neurons with examples. Describe the corticospinal (pyramidal) tract and the direct motor pathways from the cortex to the trunk
More informationIs Deep Brain Stimulation a Viable Treatment for Parkinson s Disease?
Is Deep Brain Stimulation a Viable Treatment for Parkinson s Disease? Brocha Gold Brocha Gold Is majoring in Biology Abstract Treatment options for those suffering from Parkinson s Disease are as diverse
More informationBasal Ganglia Anatomy, Physiology, and Function. NS201c
Basal Ganglia Anatomy, Physiology, and Function NS201c Human Basal Ganglia Anatomy Basal Ganglia Circuits: The Classical Model of Direct and Indirect Pathway Function Motor Cortex Premotor Cortex + Glutamate
More informationChapter 12 Nervous Tissue
9/12/11 Chapter 12 Nervous Tissue Overview of the nervous system Cells of the nervous system Electrophysiology of neurons Synapses Neural integration Subdivisions of the Nervous System 1 Subdivisions of
More informationBASAL GANGLIA. Dr JAMILA EL MEDANY
BASAL GANGLIA Dr JAMILA EL MEDANY OBJECTIVES At the end of the lecture, the student should be able to: Define basal ganglia and enumerate its components. Enumerate parts of Corpus Striatum and their important
More informationThalamus: VA VM, MD S N. GPi Superior colliculus. compacta reticulata
. Putamen & Caudate Putamen & Caudate GPe Neocortex Thalamus: VA VM, MD S N GPi Superior colliculus compacta reticulata Substantia Nigra Pedunculopontine nuc. of midbrain ret.form. Satellites of the corpus
More information05-Nov-15. Impact of Parkinson s Disease in Australia. The Nature of Parkinson s disease 21st Century
Peter Silburn Professor Clinical Neuroscience University of Queensland Queensland Brain Institute Neurosciences Queensland Impact of in Australia Second most common neurodegenerative disorder Up to 64,000
More informationAbstracts and affiliations
Dopamine Discovery Day August 30, 2012 Rikshospitalet Store auditorium, Oslo, Norway Organized by Linda H. Bergersen & Vidar Gundersen Institute of Basic Medical Sciences & Centre for Molecular Biology
More informationParkinson's Disease. Robert L. Copeland, Ph.D. Howard University College of Medicine Department of Pharmacology
Parkinson's Disease Robert L. Copeland, Ph.D. Howard University College of Medicine Department of Pharmacology 18 February 2002 Parkinson Disease Neurological disease affecting over four million patients
More informationGenotypic and phenotypic overlaps in Parkinson s disease and parkinsonisms
Genotypic and phenotypic overlaps in Parkinson s disease and parkinsonisms Enza Maria Valente CSS-Mendel Institute, Rome University of Salerno The «shaking palsy»: clinica features Involuntary tremulous
More informationThe basal ganglia (BG) are a group of nuclei located subcortically
The Basal Ganglia and Disorders of Movement: Pathophysiological Mechanisms José A. Obeso, 1 María C. Rodríguez-Oroz, 1 Manuel Rodríguez, 4 Javier Arbizu, 2 and José M. Giménez-Amaya 3 Departments of 1
More informationDRUG TREATMENT OF PARKINSON S DISEASE. Mr. D.Raju, M.pharm, Lecturer
DRUG TREATMENT OF PARKINSON S DISEASE Mr. D.Raju, M.pharm, Lecturer PARKINSON S DISEASE (parkinsonism) is a neurodegenerative disorder which affects t h e b a s a l g a n g l i a - and is associated with
More informationPARKINSON S DISEASE: current aspects of ETIOLOGY, DIAGNOSIS and TREATMENT. Dilek Ince Gunal, MD Assoc. Prof
PARKINSON S DISEASE: current aspects of ETIOLOGY, DIAGNOSIS and TREATMENT Dilek Ince Gunal, MD Assoc. Prof Definition Clinical symptoms: Pathogenesis: Etiology: Neurodegenerative syndrome with chronic,
More informationThe Parkinson s You Can t See
The Parkinson s You Can t See We principally see the motor phenomena of Parkinson's disease, but is there an early stage without visible features? Might this provide a window for disease-modifying therapy?
More informationParkinson s UK Brain Bank
Parkinson s UK Brain Bank From Brain to Breakthrough Dr George Gveric Manager 19 October 2018 Coordinated approach Donors Relatives Information Reporting Researchers Tissue supply Quality assurance Expertise
More informationParkinson s Disease Update
Parkinson s Disease Update Elise Anderson MD Providence Center for Parkinson s Disease October 26, 2017 11/6/2017 1 Disclosures GE Speaker, DaTSCAN 11/6/2017 2 Outline PD diagnosis Motor and nonmotor symptoms
More information